UnitedHealth Group (NYSE:UNH) Price Target Raised to $325.00 at Bank of America

UnitedHealth Group (NYSE:UNH) had its target price lifted by Bank of America from $290.00 to $325.00 in a report released on Monday morning,Benzinga reports. They currently have a neutral rating on the healthcare conglomerate’s stock.

A number of other analysts have also recently commented on the stock. Raymond James Financial cut shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research note on Wednesday, May 14th. Erste Group Bank downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 30th. TD Cowen downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price objective on the stock. in a report on Monday, May 19th. Robert W. Baird reaffirmed an “underperform” rating and issued a $198.00 price objective (down from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Finally, Oppenheimer dropped their price objective on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $367.71.

UnitedHealth Group Stock Up 1.6%

Shares of UnitedHealth Group stock opened at $308.84 on Monday. The firm’s 50 day moving average price is $289.03 and its 200-day moving average price is $394.17. The company has a market cap of $279.71 billion, a P/E ratio of 13.38, a PEG ratio of 1.96 and a beta of 0.43. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group has a 52-week low of $234.60 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The firm’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter last year, the business earned $6.80 earnings per share. On average, sell-side analysts predict that UnitedHealth Group will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. UnitedHealth Group’s payout ratio is presently 38.30%.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 589 shares of the business’s stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the transaction, the chief executive officer owned 10,398 shares of the company’s stock, valued at approximately $3,171,390. The trade was a 5.36% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.28% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the company. N.E.W. Advisory Services LLC boosted its stake in UnitedHealth Group by 168.8% during the second quarter. N.E.W. Advisory Services LLC now owns 1,398 shares of the healthcare conglomerate’s stock worth $436,000 after buying an additional 878 shares during the period. Geneos Wealth Management Inc. boosted its stake in UnitedHealth Group by 30.9% during the second quarter. Geneos Wealth Management Inc. now owns 10,825 shares of the healthcare conglomerate’s stock worth $3,377,000 after buying an additional 2,553 shares during the period. V2 Financial group LLC boosted its stake in UnitedHealth Group by 1,395.7% during the second quarter. V2 Financial group LLC now owns 8,645 shares of the healthcare conglomerate’s stock worth $2,697,000 after buying an additional 8,067 shares during the period. Wellington Capital Management Inc. acquired a new stake in shares of UnitedHealth Group during the second quarter worth about $342,000. Finally, Rexford Capital Inc. purchased a new position in shares of UnitedHealth Group in the second quarter valued at approximately $465,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.